International stock news

Rss Today on Proactive AU

2014-11-28

Imugene to divest Linguet™, focus on HER-Vaxx for gastric cancer

 
Imugene will divest Linguet™ to focus on HER-Vaxx, one of the world’s most advanced B cell vaccines. Her-Vaxx has potential to improve upon Roche’s blockbuster Herceptin drug that generated annualised sales of $6.9B and targets the same biomarker.
FULL ARTICLE

 

Rss Today on Proactive UK

2014-11-28

UPDATE - Nanobiotix makes funding breakthrough; will go it alone in the US

 
Nanobiotix has agreed a significant funding deal with a US investor that will broaden the scope of development of its ground-breaking advance on traditional radiotherapy.
FULL ARTICLE

 

Rss Today on Proactive US

2014-11-28

TSX retreats as OPEC refrains from cutting production

 
Canadian stocks dropped for a second day, driven by energy producers, after OPEC decided not to trim production and oil prices tumbled to a four-and-a-half year low.
FULL ARTICLE